Rafarma Pharmaceuticals Inc (RAFA)

Currency in USD
0.0235
0.0000(0.00%)
Closed·
RAFA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.02350.0298
52 wk Range
0.00360.0930
Key Statistics
Prev. Close
0.0235
Open
0.0298
Day's Range
0.0235-0.0298
52 wk Range
0.0036-0.093
Volume
48.13K
Average Vol. (3m)
28.37K
1-Year Change
-41.5652%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RAFA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RAFA Income Statement

Compare RAFA to Peers and Sector

Metrics to compare
RAFA
Peers
Sector
Relationship
P/E Ratio
0.0x−0.8x−0.3x
PEG Ratio
0.00−0.010.00
Price / Book
0.0x1.2x2.6x
Price / LTM Sales
0.0x2.4x3.0x
Upside (Analyst Target)
0.0%186.7%61.2%
Fair Value Upside
Unlock6.0%7.2%Unlock

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.

People Also Watch

45.90
ORINY
-2.34%
5.4
NPPNY
0.00%
0.0003
KOAN
0.00%

FAQ

What Is the Rafarma Pharmaceuticals (RAFA) Stock Price Today?

The Rafarma Pharmaceuticals stock price today is 0.0235 USD.

What Stock Exchange Does Rafarma Pharmaceuticals Trade On?

Rafarma Pharmaceuticals is listed and trades on the OTC Markets.

What Is the Stock Symbol for Rafarma Pharmaceuticals?

The stock symbol for Rafarma Pharmaceuticals is "RAFA."

What Is the Rafarma Pharmaceuticals Market Cap?

As of today, Rafarma Pharmaceuticals market cap is 2.0600M USD.

What Is Rafarma Pharmaceuticals's Earnings Per Share (TTM)?

The Rafarma Pharmaceuticals EPS (TTM) is -0.0144.

From a Technical Analysis Perspective, Is RAFA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Rafarma Pharmaceuticals Stock Split?

Rafarma Pharmaceuticals has split 1 times.

What is the current trading status of Rafarma Pharmaceuticals (RAFA)?

As of Oct 11, 2026, Rafarma Pharmaceuticals (RAFA) is trading at a price of 0.0235 USD, with a previous close of 0.0235 USD. The stock has fluctuated within a day range of 0.0235 USD to 0.0298 USD, while its 52-week range spans from 0.0036 USD to 0.0930 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.